In the international scenario, Aché has been expanding its activities with product licensing agreements for years, either to bring innovations in many medical specialties to Brazil or to take renowned brands to countries in the Americas, Africa, and Asia.
Acheflan, for example, achieved the patent grant in Europe until 2024. The registration was granted by the EPO (European Patent Office). This represents a milestone for Aché and Brazilian science.
Currently, we export 32 medicines and 57 presentations to the Americas, Africa, and Japan, maintaining successful partnerships with 23 international pharmaceutical companies for the licensing and trading of innovative products in Brazil.
The Company is open to the best opportunities. If you would like to present new business ideas with products, please access the form below.